DR. K. Lefebvre SRL
DR. K. Lefebvre reported total assets of 388,307 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of DR. K. Lefebvre shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets -36 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. K. Lefebvre's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 231,418 € | ||||
| Equity | 2,000 € | ||||
| Cash | 21,159 € | ||||
| EBITDA | 325,164 € | ||||
| Total assets | 388,307 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 26 Sep 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
DR. K. Lefebvre's financial analysis
- Solvency0.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. K. Lefebvre
DR. K. Lefebvre's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0729.573.127
- VAT number
- BE0729573127
- Peppol
- Registered · 0208:0729573127 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jun 2019
- Registered office
- 9100 Sint-Niklaas
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
DR. K. Lefebvre (SRL) has been based in Sint-Niklaas since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 231,418 € and equity of 2,000 €; its revenue is not published. Its solvency stands at 0.5%, below the median of its sector (72.2%).
Companies similar to DR. K. Lefebvre
Companies in the same business, of comparable size and area, outside its group.
- Dr. Hannes Ruymbeke Medical specialists activities Temse · balance sheet 389,419 €
- Dr. D. SCHAERLAKEN Stomatologie, MKA-chirurgie Medical specialists activities Kontich · balance sheet 388,181 €
- MD MHC Decoster Medical specialists activities Kortenberg · balance sheet 388,105 €
- Dr. Laure Dequeker Medical specialists activities Kortrijk · balance sheet 388,046 €
- Tabolcea Pavel Medical specialists activities Braine-l'Alleud · balance sheet 388,019 €
- Ocumedi Medical specialists activities Lint · balance sheet 388,643 €
- Romapo Medical specialists activities Jurbise · balance sheet 388,654 €
- Dr. MEDAER KAREN Medical specialists activities Aartselaar · balance sheet 388,663 €
Frequently asked questions about DR. K. Lefebvre
What is the revenue of DR. K. Lefebvre?
DR. K. Lefebvre files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. K. Lefebvre?
In Belgium, the VAT number is the company number prefixed with BE: BE0729573127 for DR. K. Lefebvre, if the company is VAT-registered. Its company number (CBE) is 0729.573.127.
Where is the registered office of DR. K. Lefebvre?
According to the CBE register, the registered office of DR. K. Lefebvre is in 9100 Sint-Niklaas.
What is the equity of DR. K. Lefebvre?
At the close of the 2025 financial year, the equity of DR. K. Lefebvre amounts to 2,000 €, a solvency of 0.5% of total assets.
Who manages DR. K. Lefebvre?
The register lists 1 active mandates at DR. K. Lefebvre. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. K. Lefebvre
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →